Legal status by country
Is Mifepristone legal?
Written by Aaron CuhaReviewed Sep 2026
How Mifepristone is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Approved | Approved | Approved | Approved |
| Classification | FDA-approved, prescription only | Licensed, prescription only (MHRA) | TGA-registered, prescription only | Health Canada approved, prescription only |
| Note | Two separate approvals, for Cushing's syndrome hyperglycaemia and for medical termination of pregnancy. The latter is subject to a restricted distribution programme. No ageing indication. | None recorded | None recorded | None recorded |
US FDA status: FDA-approved as Korlym for hyperglycaemia secondary to hypercortisolism in Cushing's syndrome, and as Mifeprex for medical termination of pregnancy. Not approved for any ageing indication.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.